JPS56139484A - Heterocyclic compound - Google Patents

Heterocyclic compound

Info

Publication number
JPS56139484A
JPS56139484A JP3190381A JP3190381A JPS56139484A JP S56139484 A JPS56139484 A JP S56139484A JP 3190381 A JP3190381 A JP 3190381A JP 3190381 A JP3190381 A JP 3190381A JP S56139484 A JPS56139484 A JP S56139484A
Authority
JP
Japan
Prior art keywords
heterocyclic compound
heterocyclic
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP3190381A
Other languages
English (en)
Other versions
JPH0366311B2 (ja
Inventor
Baruteru Geruharuto
Esu Shiyunaidaa Kurausu
Ueebaa Kaaruuhaintsu
Fuyugunaa Arumin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CH Boehringer Sohn AG and Co KG
Original Assignee
CH Boehringer Sohn AG and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CH Boehringer Sohn AG and Co KG filed Critical CH Boehringer Sohn AG and Co KG
Publication of JPS56139484A publication Critical patent/JPS56139484A/ja
Publication of JPH0366311B2 publication Critical patent/JPH0366311B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/20—Dibenz [b, e] azepines; Hydrogenated dibenz [b, e] azepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/16—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D267/20—[b, f]-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D281/16—[b, f]-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP3190381A 1980-03-08 1981-03-05 Heterocyclic compound Granted JPS56139484A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803008944 DE3008944A1 (de) 1980-03-08 1980-03-08 Dibenzimidazoazepine, ihre herstellung und verwendung

Publications (2)

Publication Number Publication Date
JPS56139484A true JPS56139484A (en) 1981-10-30
JPH0366311B2 JPH0366311B2 (ja) 1991-10-16

Family

ID=6096617

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3190381A Granted JPS56139484A (en) 1980-03-08 1981-03-05 Heterocyclic compound

Country Status (29)

Country Link
US (1) US4313931A (ja)
EP (1) EP0035749B1 (ja)
JP (1) JPS56139484A (ja)
AU (1) AU535359B2 (ja)
BG (1) BG33886A3 (ja)
CA (1) CA1150253A (ja)
CS (2) CS221288B2 (ja)
DD (1) DD156708A5 (ja)
DE (2) DE3008944A1 (ja)
DK (1) DK154299C (ja)
ES (1) ES8301481A1 (ja)
FI (1) FI70898C (ja)
GB (1) GB2071095B (ja)
GR (1) GR74805B (ja)
HK (1) HK63186A (ja)
HU (1) HU180628B (ja)
IE (1) IE51015B1 (ja)
IL (1) IL62309A (ja)
MX (1) MX6869E (ja)
NO (1) NO162073C (ja)
NZ (1) NZ196446A (ja)
PH (1) PH15839A (ja)
PL (1) PL132141B1 (ja)
PT (1) PT72631B (ja)
RO (1) RO81652B (ja)
SU (1) SU1015829A3 (ja)
UA (1) UA8041A1 (ja)
YU (1) YU42557B (ja)
ZA (1) ZA811500B (ja)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003286287A (ja) * 2002-03-29 2003-10-10 Konica Chemical Corp 塩酸エピナスチン高融点型結晶の製造法
JP2004292364A (ja) * 2003-03-27 2004-10-21 Konica Minolta Chemical Co Ltd 塩酸エピナスチンの製造方法
JP2005508364A (ja) * 2001-10-26 2005-03-31 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規乾燥及び水性エピナスチン−シロップ製剤
JP2010120960A (ja) * 2010-02-17 2010-06-03 Dainippon Printing Co Ltd 塩酸エピナスチンの製造方法
JP4789383B2 (ja) * 1999-12-03 2011-10-12 ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト 高温融解結晶変態のエピナスチン塩酸塩の生成方法
JP2013151484A (ja) * 2011-12-28 2013-08-08 Towa Yakuhin Kk イソウレア化合物を用いるエピナスチンの製造方法

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3134672A1 (de) * 1981-09-02 1983-03-17 Boehringer Ingelheim KG, 6507 Ingelheim Heterocyclische verbindungen, ihre herstellung und verwendung
EP0130202A1 (en) * 1982-12-30 1985-01-09 Beecham Group Plc Tetracyclic compounds
DE4102148A1 (de) * 1991-01-25 1992-07-30 Boehringer Ingelheim Kg Verfahren zur herstellung von 3-amino-9,13b-dihydro-1h-dibenz-(c,f)imidazol(1,5-a)azepin-hydrochlorid
DE19542281C2 (de) * 1995-11-14 1997-12-04 Boehringer Ingelheim Kg Verwendung von Epinastin für die Behandlung der Migräne
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
US7776315B2 (en) * 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
US20100310477A1 (en) * 2000-11-28 2010-12-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg. Pharmaceutical compositions based on anticholingerics and additional active ingredients
DK1496051T3 (da) * 2002-04-11 2007-03-26 Konica Minolta Chemical Co Ltd Fremgangsmåde til fremstilling af 6-aminomethyl-6,11-dihydro-5H-dibenz[b,e]azepin
US8758816B2 (en) * 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US20070020330A1 (en) * 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
ES2704482T3 (es) 2004-11-24 2019-03-18 Meda Pharmaceuticals Inc Composiciones que comprenden azelastina y sus métodos de uso
US20090143359A1 (en) * 2005-07-08 2009-06-04 Akiharu Isowaki Percutaneously Absorptive Ophthalmic Preparation Comprising Epinastine
US7247623B2 (en) * 2005-08-19 2007-07-24 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with non-drying antihistamines
KR101386530B1 (ko) 2006-12-29 2014-04-18 케이피엑스 라이프사이언스 주식회사 순도 및 수율이 향상된3-아미노-9,13ｂ디하이드로-1Ｈ-디벤즈-[ｃ,ｆ]이미다조[1,5-ａ]-아제핀 염산염의 제조방법
WO2009063504A2 (en) * 2007-09-24 2009-05-22 Usv Limited Novel crystal modification of epinastine or salts thereof and process for preparation thereof
WO2010021681A2 (en) * 2008-08-18 2010-02-25 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
CN103172638B (zh) * 2013-03-13 2015-09-16 北京朗依制药有限公司 一种盐酸依匹斯汀的制备方法
CN104098575B (zh) * 2013-04-15 2016-06-01 四川科瑞德凯华制药有限公司 一种盐酸依匹斯汀晶型及其制备方法和用途
KR102041389B1 (ko) 2017-12-12 2019-11-27 (주)프론트바이오 N-(9,13b-디하이드로-1H-디벤조[c,f]이미다조[1,5-a]아제핀-3-일)-2-하이드록시벤즈아미드 및 2-((9,13b-디하이드로-1H-디벤조[c,f]이미다조[1,5-a]아제핀-3-일) 카바모일)페닐 아세테이트의 화합물, 이의 제조방법 및 이를 포함하는 항염증 및 진통제 조성물
KR102080239B1 (ko) 2019-08-06 2020-02-21 한양대학교 에리카산학협력단 에피나스틴의 신규 제조방법

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4844300A (ja) * 1971-10-05 1973-06-26
JPS4899198A (ja) * 1972-03-07 1973-12-15
JPS5168598A (ja) * 1974-10-28 1976-06-14 Akzo Nv

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4844300A (ja) * 1971-10-05 1973-06-26
JPS4899198A (ja) * 1972-03-07 1973-12-15
JPS5168598A (ja) * 1974-10-28 1976-06-14 Akzo Nv

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4789383B2 (ja) * 1999-12-03 2011-10-12 ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト 高温融解結晶変態のエピナスチン塩酸塩の生成方法
JP2005508364A (ja) * 2001-10-26 2005-03-31 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規乾燥及び水性エピナスチン−シロップ製剤
JP2003286287A (ja) * 2002-03-29 2003-10-10 Konica Chemical Corp 塩酸エピナスチン高融点型結晶の製造法
JP2004292364A (ja) * 2003-03-27 2004-10-21 Konica Minolta Chemical Co Ltd 塩酸エピナスチンの製造方法
JP4514017B2 (ja) * 2003-03-27 2010-07-28 大日本印刷株式会社 塩酸エピナスチンの製造方法
JP2010120960A (ja) * 2010-02-17 2010-06-03 Dainippon Printing Co Ltd 塩酸エピナスチンの製造方法
JP2013151484A (ja) * 2011-12-28 2013-08-08 Towa Yakuhin Kk イソウレア化合物を用いるエピナスチンの製造方法

Also Published As

Publication number Publication date
DD156708A5 (de) 1982-09-15
YU56881A (en) 1983-10-31
GB2071095B (en) 1983-06-02
FI810712L (fi) 1981-09-09
DK154299B (da) 1988-10-31
PL132141B1 (en) 1985-02-28
RO81652A (ro) 1983-04-29
US4313931A (en) 1982-02-02
DK154299C (da) 1989-03-28
CS221288B2 (en) 1983-04-29
NO162073C (no) 1989-11-01
YU42557B (en) 1988-10-31
AU6815881A (en) 1981-09-17
PH15839A (en) 1983-04-08
AU535359B2 (en) 1984-03-15
ZA811500B (en) 1982-11-24
IL62309A (en) 1984-06-29
ES500150A0 (es) 1982-12-01
BG33886A3 (en) 1983-05-16
EP0035749B1 (de) 1984-06-06
IL62309A0 (en) 1981-05-20
PT72631B (fr) 1982-12-30
DE3008944A1 (de) 1981-09-24
RO81652B (ro) 1983-04-30
CS410491A3 (en) 1992-05-13
UA8041A1 (uk) 1995-12-26
EP0035749A1 (de) 1981-09-16
FI70898B (fi) 1986-07-18
DK103581A (da) 1981-09-09
NO162073B (no) 1989-07-24
FI70898C (fi) 1986-10-27
PL230036A1 (ja) 1982-05-24
SU1015829A3 (ru) 1983-04-30
HU180628B (en) 1983-03-28
NZ196446A (en) 1984-07-06
MX6869E (es) 1986-09-11
JPH0366311B2 (ja) 1991-10-16
PT72631A (fr) 1981-04-01
GR74805B (ja) 1984-07-12
IE51015B1 (en) 1986-09-03
GB2071095A (en) 1981-09-16
DE3163938D1 (en) 1984-07-12
CA1150253A (en) 1983-07-19
HK63186A (en) 1986-09-05
IE810485L (en) 1981-09-08
NO810762L (no) 1981-09-09
ES8301481A1 (es) 1982-12-01

Similar Documents

Publication Publication Date Title
JPS56154464A (en) Heterocyclic compound
GB2078719B (en) Heterocyclic compounds
DE3172252D1 (en) Heterocyclic compounds
ZW19381A1 (en) Heterocyclic compounds
GB2119801B (en) Heterocyclic compounds
ZA815541B (en) Heterocyclic compounds
GB8315564D0 (en) Heterocyclic compounds
JPS56139484A (en) Heterocyclic compound
ZA815540B (en) Heterocyclic compounds
JPS5791986A (en) Heterocyclic compounds
GB2083463B (en) Heterocyclic compounds
JPS5767568A (en) Benzisoselenazolone compound
JPS57120588A (en) Nortropanol compound
GB8300095D0 (en) Heterocyclic compounds
PT76791A (en) Heterocyclic compounds
GB2083476B (en) Heterocyclic compounds
JPS57120575A (en) Imidazolylphenylamidine compound
GB2082175B (en) Heterocyclic compounds
JPS5724328A (en) Dienylmethacrylate compound
ZA813354B (en) Heterocyclic compounds
JPS56152469A (en) Substituted triarylthiazole compound
DE3377060D1 (en) Heterocyclic compounds
JPS5749666A (en) Helichromic compound
GB8325760D0 (en) Heterocyclic compounds
ZA818703B (en) Heterocyclic compounds